10 Oral: AKY-1189, a novel, first-in-class miniprotein radiopharmaceutical designed to deliver Actinium-225 (225Ac) to Nectin-4 expressing tumors with broad therapeutic applications in metastatic urothelial carcinoma (mUC) and other Nectin-4 expressing tumors

• DOI: 10.1016/j.ejca.2024.114539
• Publication Date: 2024-10-25T13:20:18Z
• Authors: M. Sathekge; H. Ndlovu; J. Kabunda; A. Mdlophane; K. Ramonaheng; S. Mdanda; M. Shungube; Y. Mzizi; M. Qebetu; R. Sebatana; K. Mokoala; K. Mashigoane; K. Zane; S. More; M. Vorster; K. Nasr; T. Morley; J. Kovacs; J. Horton; K. Herrmann